Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy

Ann Oncol. 2008 Dec;19(12):2089-90. doi: 10.1093/annonc/mdn645. Epub 2008 Oct 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Asian People
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives*
  • Female
  • Genetic Predisposition to Disease*
  • Glucuronosyltransferase / genetics*
  • Humans
  • Irinotecan
  • Male
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*
  • Polymorphism, Genetic

Substances

  • Antineoplastic Agents, Phytogenic
  • Irinotecan
  • UGT1A1 enzyme
  • Glucuronosyltransferase
  • Camptothecin